Complementary Integrative Rehabilitation Medicine
Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)
Treatments with long-term benefit for attention-deficit/hyperactivity disorder (ADHD) are needed; one of the more promising is Neurofeedback (EEG Biofeedback), which has several Randomized controlled trials showing significant benefit, but which are inconclusive because they were not Double-Blinded; the benefit could have been nonspecific (placebo response). Because of Neurofeedback's labor-intensive cost, it is important to know how much specific benefit it yields. This presentation will review and critique the evidence base for neurofeedback (EEG biofeedback (NF) as treatment for ADHD and unveil preliminary results of an NIMH-funded double-blind 2-site randomized clinical trial (RCT) designed to address flaws of previous studies.